Gold nanoparticles, covalently functionalised with the photosensitiser C11Pc and PEG, were actively targeted towards epidermal growth factor receptor overexpressing cancers using the peptide FITC-βAAEYLRK, with selective phototoxicty observed.
Inhibiting the protein-protein interaction between programmed cell death 1 (PD-1) and its ligand programmed cell death ligand 1 (PD-L1) has become a focal point in immunotherapy for cancer treatments. Limitations of antibody treatments remain prevalent leaving an urgent need for alternative inhibitors of PD-1/PD-L1. Utilizing the photo-switching ability of the well studied azobenzenes, we developed a photo-controlled PD-1/PD-L1 peptide inhibitor. The azobenzene peptide selectively inhibits the PD-1/PD-L1 interaction when in the cis isomer, while showing no appreciable inhibition in the trans isomer. The light-activated inhibitor demonstrated improved activity compared to the canonical peptide it was derived from in a luminescent cell-based PD-1/PD-L1 blockade assay. The light-activated peptide demonstrates the applicatbilty of photoisomerization for mimicking β-hairpin motifs in PD-1/PD-L1 inhibition.
The synthesis of the ethyl ester analogue of the ultapotent antitumour antibiotic seco-duocarmycin SA has been achieved in eleven linear steps from commercially available starting materials. The DSA alkylation subunit can be made in ten linear steps from the same precursor. The route involves CH activation at the equivalent of the C7 position on indole leading to a borylated intermediate 9 that is stable enough for coupling reactions but can be easily converted to the free hydroxyl analogue.